John Northcott

VP, Marketing, Comm Strategy, Lexicon Pharmaceuticals.

Companies

Nektar TherapeuticsSVP & Chief Commercial Officer Dec 4, 2019 to May 17, 2022¹
Lexicon PharmaceuticalsVP, Marketing, Comm Strategy Jul 29, 2014 to Mar 3, 2015²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Nektar Therapeutics NKTR223,210 shares³$8.4M at $37.72May 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 16, 2022Sold 4,592 shares at $3.95 of Nektar Therapeutics³
Feb 16, 2022Sold 4,852 shares at $10.95 of Nektar Therapeutics⁴
Dec 16, 2021Granted 37,800 shares of Nektar Therapeutics⁵
Nov 16, 2021Sold 6,061 shares at $13.16 of Nektar Therapeutics⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNektar Therapeutics, SVP & Chief Commercial Officer
2
SEC EDGARLexicon Pharmaceuticals, VP, Marketing, Comm Strategy
3
SEC EDGARNektar Therapeutics shares after the filing of May 16, 2022
4
SEC EDGARForm 4 filed Feb 18, 2022
5
SEC EDGARForm 4 filed Dec 20, 2021
6
SEC EDGARForm 4 filed Nov 17, 2021